Given that YAP induces FOXM1 in our cell lines, and that FOXM1 has been proposed to be a therapeutic target in breast cancer [20], we next sought to assess whether FOXM1 inhibition induces CCA cell death. Here, FOXM1 is linked to cholangiocarcinoma.